acetylcysteine has been researched along with Granulomatous Disease, Chronic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ank, BJ; Aroda, VR; Roberts, RL | 1 |
Dahlgren, C; Follin, P; Lew, D; Ohman, L; Stendahl, O | 1 |
2 other study(ies) available for acetylcysteine and Granulomatous Disease, Chronic
Article | Year |
---|---|
N-acetylcysteine enhances antibody-dependent cellular cytotoxicity in neutrophils and mononuclear cells from healthy adults and human immunodeficiency virus-infected patients.
Topics: Acetylcysteine; Adolescent; Adult; Antibody-Dependent Cell Cytotoxicity; Antioxidants; Carmustine; Child; Child, Preschool; Female; Glutathione; Granulomatous Disease, Chronic; HIV Infections; Humans; Infant; Leukocytes, Mononuclear; Male; Neutrophils | 1995 |
N-acetylcysteine enhances receptor-mediated phagocytosis by human neutrophils.
Topics: Acetylcysteine; Catalase; Granulomatous Disease, Chronic; Humans; In Vitro Techniques; Luminescent Measurements; Neutrophils; Phagocytosis; Receptors, Cell Surface; Saccharomyces cerevisiae; Stimulation, Chemical | 1992 |